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Oxaliplatin is one of the most effective anticancer drug, particularly employed 
in the treatment of colorectal cancer, but one of the major limitation in its use is 
peripheral neurotoxicity. Oxaliplatin induced peripheral neurotoxicity (OIPN) has a 
high incidence and is frequently long lasting or permanent. Neuropathy is character-
ized by distal sensory impairment initially in the legs, then extending to the arms. 
A prominent manifestation of sensitive damage is ataxia. Besides chronic neurotox-
icity, many patients experience an acute, rapidly developing cold-induced sensory 
neuropathy, usually resolving within one week. OIPN clinical manifestations reflect 
the involvement of dorsal root ganglia (DRG) as primary target of the drug toxicity. 
Although this assumption is largely accepted and some pathogenetic hypothesis have 
been proposed, mechanisms at the basis of OIPN need to be clearly defined. OIPN 
may vary in frequency and severity among different cancer patients despite equal 
treatment schedules. A genetic susceptibility for more severe oxaliplatin-induced 
peripheral neurotoxicity (OIPN) has been suggested but never confirmed. Therefore 
we designed a study to assess the phenotypic differences induced by oxaliplatin 
treatment in six different mice strains (Balb c, AJ, C57Bl6, FVB, DBA, CD1) aiming 
at identifying the more and less severely affected. Animals were treated with OHP 
3.5 mg/Kg/iv twice weekly x 4 weeks and evaluated before and after treatment. In 
all strains we performed a multimodal characterization of its neurotoxicity through 
morphological and morphometrical assessment in caudal nerve and DRG at light and 
electron microscopy, intra-epidermal nerve fibers density quantification, evaluation of 
mechanical and cold allodynia/hypoaesteshesia, caudal and digital nerve conduction 
velocity, activity of wide dynamic range (WDR) neurons of the spinal dorsal horn. 
Our preliminary data suggest that all the strains show signs of OIPN but not the 
same modifications in the parameters examined. We will show these results with par-
ticular attention to morphological data. This study suggests that genetic variability 
might have a role in the type and severity of OHP-induced peripheral damage.
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